Merck & Co Inc (MRK)
80.77
+0.94 +1.18%
NYSE
Feb 22, 20:00
Delayed 2m
USD
View All Key Stats
MRK Key Stats
| Income Statement | |
| Revenue (TTM) | 42.29B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.32 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 6.22B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 70.09% |
| Profit Margin (Quarterly) | 16.61% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 210.03B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 5.117 |
| PE Ratio (TTM) | 34.81 |
| Price to Book Value | 6.478 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 2.14B |
| Return on Equity (TTM) | Upgrade |
View All MRK News
MRK News
-
WireHeadlineTime (ET)
-
Yahoo02/22 19:15
-
Yahoo02/22 17:08
-
Yahoo02/22 09:21
-
MT Newswires02/22 09:09
-
Yahoo02/22 09:04
-
Yahoo02/22 07:41
-
SA Breaking News02/22 07:40
-
MT Newswires02/22 07:14
-
MT Newswires02/21 16:40
-
PR Newswire02/21 13:51
View All Events
MRK Events
| Date | Type | Description |
|---|---|---|
| 01/31/2020 08:00 EST | Misc | Merck & Co Inc Fourth Quarter Earnings Conference Call in 2019 |
| 01/31/2020 | Earnings | Merck & Co Inc Fourth Quarter Earnings in 2019 Release |
| 10/29/2019 08:00 EDT | Misc | Merck & Co Inc Third Quarter Earnings Conference Call in 2019 |
| 10/29/2019 | Earnings | Merck & Co Inc Third Quarter Earnings in 2019 Release |
| 07/30/2019 08:00 EDT | Misc | Merck & Co Inc Second Quarter Earnings Conference Call in 2019 |
| 07/30/2019 | Earnings | Merck & Co Inc Second Quarter Earnings in 2019 Release |
| 04/30/2019 08:00 EDT | Misc | Merck & Co Inc First Quarter Earnings Conference Call in 2019 |
| 04/30/2019 | Earnings | Merck & Co Inc First Quarter Earnings Results in 2019 |
| 03/14/2019 | Dividends | Amount: 0.55, Declared Date: Jan 29 2019, Pay Date: Apr 05 2019 |
| 02/01/2019 08:00 EST | Misc | Merck & Co Inc Fourth Quarter Earnings Conference Call in 2018 |
MRK Fundamentals
Income Statement View Statement
MRK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MRK One Page Reports
- One Page Report Download
MRK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 80.77 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.merck.com
- Investor Relations URL: http://investors.merck.com/investors/default.aspx
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Apr. 30, 2019
- Last Earnings Release: Feb. 01, 2019
- Next Ex-Dividend Date: Mar. 14, 2019
- Last Ex-Dividend Date: Dec. 14, 2018
- Description: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the company's sales are generated in the United States.
MRK Excel Add-In Codes
- Name: =YCI("MRK","name")
- Description: =YCI("MRK","description")
- Sector: =YCI("MRK","sector")
- Industry: =YCI("MRK","industry")
- Est. Current Fiscal Year End: =YCI("MRK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MRK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MRK Tweets Stocktwits
Advertisement
